| Literature DB >> 33603424 |
Gebremedhin Gebreegziabiher1, Tefera Belachew2, Kibriti Mehari3, Dessalegn Tamiru2.
Abstract
BACKGROUND: Metabolic Syndrome (MetS) is becoming a big public health problem in developing countries like Ethiopia. Developing countries have an almost two-fold higher risk of death due to non-communicable diseases (NCDs) compared to high-income countries. This study aimed to assess the magnitude and factors associated with MetS among adult residents of Mekelle city.Entities:
Keywords: Northern Ethiopia; adult; magnitude; metabolic syndrome
Year: 2021 PMID: 33603424 PMCID: PMC7882458 DOI: 10.2147/DMSO.S287281
Source DB: PubMed Journal: Diabetes Metab Syndr Obes ISSN: 1178-7007 Impact factor: 3.168
Socio-Demographic, Lifestyle, and Clinical Characteristics of the Participants (n=266)
| Variables | Categories | All (n=266) n (%) | Men=124 (46.6%) | Women=142 (53.4%) | p-valuea |
|---|---|---|---|---|---|
| Age (mean (SD)) | 37.96 (14.76) | 39.18 (14.87) | 36.89 (14.64) | 0.209b | |
| Marital status | Single | 73 (27.4) | 46 (37.1) | 27 (19.0) | 0.003* |
| Married | 179 (67.3) | 74 (59.7) | 105 (73.9) | ||
| Others c | 14 (5.3) | 4 (3.2) | 10 (7.0) | ||
| Educational status | No formal education | 27 (10.1) | 6 (4.8) | 21 (14.8) | 0.007* |
| Literate | 239 (89.9) | 118 (95.2) | 121 (85.2) | ||
| Occupation | Employed | 98 (36.8) | 67 (54.0) | 31 (21.8) | <0.001* |
| Housewife | 63 (23.7) | 0 (0.0) | 63 (43.7) | ||
| Merchant | 53 (19.3) | 30 (24.2) | 23 (16.2) | ||
| Daily laborer | 14 (5.3) | 9 (7.3) | 5 (3.5) | ||
| Student | 9 (3.4) | 0 (0.0) | 9 (6.3) | ||
| Others d | 30 (11.3) | 18 (14.5) | 12 (8.5) | ||
| Number of family members | 1–3 | 91 (34.2) | 46 (37.1) | 45 (31.7) | 0.647 |
| 4–6 | 133 (50.0) | 59 (47.6) | 74 (52.1) | ||
| ≥7 | 42 (15.8) | 19 (15.3) | 23 (16.2) | ||
| Current smoker | Yes | 13 (4.9) | 13 (10.5) | 0 (0.0) | <0.001* |
| No | 253 (95.1) | 111 (89.5) | 142 (100.0) | ||
| Alcohol consumption (current) | Yes | 215 (80.8) | 108 (87.1) | 107 (75.4) | 0.015* |
| No | 51 (19.2) | 16 (12.9) | 35 (24.6) | ||
| Living with smokers (current) | Yes | 11 (4.1) | 7 (5.6) | 4 (2.8) | 0.248 |
| No | 255 (95.9) | 117 (94.4) | 138 (97.2) | ||
| No | 262 (98.5) | 123 (99.2) | 139 (97.9) | ||
| Formal exercise | Yes | 11 (4.1) | 10 (8.1) | 1 (0.7) | 0.003* |
| No | 255 (95.9) | 114 (91.9) | 141 (99.3) | ||
| Intensity of activity of daily work | Low | 25 (9.4) | 18 (14.5) | 7 (4.9) | 0.027* |
| Moderate | 210 (78.9) | 93 (75.0) | 117 (82.4) | ||
| Vigorous | 31 (11.7) | 13 (10.5) | 18 (12.7) | ||
Notes: *Significant difference, aChi-square test, bStudent ’s t-test, cdivorced, widowed, separated, and temporary relationship, dbroker and driver.
Abbreviation: N/A, not applicable.
Prevalence of Metabolic Syndrome and Its Components Stratified by Sex (n = 266)
| Variables | Categories | Overall (n=266) n (%) | Gender | P-value (X2) | |
|---|---|---|---|---|---|
| Men (n=124) n (%) | Women (n=142), n (%) | ||||
| MetS | Yes | 58 (21.8) | 23 (18.5) | 35 (24.6) | 0.238 |
| No | 208 (78.2) | 101 (81.5) | 107 (75.4) | ||
| Waist circumference (M/W) | <94/80 cm | 155 (58.3) | 92 (74.2) | 63 (44.4) | <0.001* |
| ≥94/80 cm | 111 (41.7) | 32 (25.8) | 79 (55.6) | ||
| Fasting Blood glucose | <100 mg/dL | 209 (78.6) | 93 (75.0) | 116 (81.7) | 0.231 |
| ≥100 mg/dL | 57 (21.4) | 31 (25.0) | 26 (18.3) | ||
| Triglyceride | <150 mg/dL | 165 (62.0) | 65 (52.4) | 100 (70.4) | 0.003* |
| ≥150 mg/dL | 101 (38.0) | 59 (47.6) | 42 (29.6) | ||
| HDL-C (M/W) | 228 (85.7) | 114 (91.9) | 114 (80.3) | 0.008* | |
| <40/50 mg/dL | 38 (14.3) | 10 (8.1) | 28 (19.7) | ||
| Blood pressure | Normal (<130/85) | 153 (57.5) | 71 (57.3) | 82 (57.7) | 0.936 |
| Raised (≥130/85) | 113 (42.5) | 53 (42.7) | 60 (42.3) | ||
| SBP | <130 mmHg | 176 (66.2) | 82 (66.1) | 94 (66.2) | 0.991 |
| ≥130 mmHg | 90 (33.8) | 42 (33.9) | 48 (33.8) | ||
| DBP | <85 mmHg | 179 (67.3) | 81 (65.3) | 98 (69.0) | 0.600 |
| ≥85 mmHg | 87 (32.7) | 43 (34.7) | 44 (31.0) | ||
Note: *Significant difference.
Abbreviations: MetS, metabolic syndrome; SBP, systolic blood pressure, DBP, diastolic blood pressure; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; M/W, men/women.
The Distribution of MetS Among the Participants Stratified by Sex (n=266)
| Variables | Categories | Metabolic Syndrome | |||
|---|---|---|---|---|---|
| Overall (%) 58 (21.8%)) | Men (%) 23 (18.5%) | Women (%) 35(24.6%) | p-value (X2) 0.229 | ||
| Age | 20–39 | 19 (11.3) | 8 (10.8) | 11 (11.7) | 0.790 |
| ≥40 | 39 (39.8) | 15 (30.0) | 24 (50.0) | ||
| Monthly income (ranked) | Low | 9 (8.8) | 1 (1.9) | 8 (16.7) | 0.018* |
| Medium | 21 (25.3) | 13 (30.2) | 8 (20.0) | ||
| High | 28 (34.6) | 9 (33.3) | 19 (35.2) | ||
| Fasting blood glucose | Normal | 26 (12.4) | 8 (8.6) | 18 (15.5) | 0.255 |
| Pre-diabetes | 16 (45.7) | 9 (47.4) | 7 (43.8) | ||
| Diabetes | 16 (72.7) | 6 (50.0) | 10 (100.0) | ||
| Triglyceride | <150 | 9 (5.5) | 2 (3.1) | 7 (7.0) | 0.220 |
| 150–199 | 14 (35.9) | 4 (20.0) | 10 (52.6) | ||
| ≥200 | 35 (56.5) | 17 (43.6) | 18 (78.3) | ||
| Total cholesterol | <200 | 26 (13.9) | 11 (12.4) | 15 (15.3) | 0.929 |
| 200–239 | 19 (40.4) | 7 (31.8) | 12 (48.0) | ||
| ≥240 | 13 (40.6) | 5 (38.5) | 8 (42.1) | ||
| HDL-C (M/W) | ≥40/50 | 38 (16.7) | 114(91.9) | 114(80.3) | 0.098 |
| <40/50 | 20 (52.6) | 10 (8.1) | 28 (19.7) | ||
| LDL-C | <130 | 14 (10.6) | 5 (7.7) | 9 (13.4) | 0.904 |
| 130–159 | 13 (28.9) | 5 (25.0) | 8 (32.0) | ||
| 160–189 | 10 (25.6) | 5 (27.8) | 5 (23.8) | ||
| ≥190 | 21 (42.0) | 8 (38.1) | 13 (44.8) | ||
| Systolic blood pressure | <130 mmHg | 16 (9.1) | 8 (9.8) | 8 (8.5) | 0.320 |
| ≥130 mmHg | 42 (46.7) | 15 (35.7) | 27 (56.3) | ||
| Diastolic blood pressure | <85 mmHg | 19 (10.6) | 6 (7.4) | 13 (13.3) | 0.380 |
| ≥85 mmHg | 39 (44.8) | 17 (39.5) | 22 (50.0) | ||
| Body mass index | Underweight | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.044* |
| Normal | 16 (10.7) | 5 (6.9) | 11 (14.1) | ||
| Overweight | 24 (38.1) | 14 (41.2) | 10 (34.5) | ||
| Obese | 18 (66.7) | 4 (50.0) | 14 (73.7) | ||
| WC (cm) (M/W) | <94/80 | 0 (0.0) | 0 (0.0) | 0 (0.0) | NA |
| ≥94/80 | 58 (52.3) | 23 (71.9) | 35 (44.3) | ||
| W-Ht-R (M/W) | <0.49/0.50 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.901 |
| ≥0.49/0.50 | 58 (36.7) | 23 (31.5) | 35 (41.2) | ||
| W-Hip-R (M/W) | <0.88/0.82 | 2 (2.5) | 1 (2.2) | 1 (2.9) | 0.039* |
| ≥0.88/0.82 | 56 (30.1) | 22 (27.8) | 34 (31.8) | ||
Note: *Significant difference.
Abbreviations: HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; M/W, men/women; SD, standard deviation; WC, waist circumference; W-Ht-R, waist to height ratio; W-Hip-R, waist to hip ratio.
Figure 1Variation of different metabolic disorders with BMI cutoffs among the participants (n = 266).
Figure 2Variation in the mean value of different CVD risk factors with MetS status of the participants (n = 266).
Factors Associated with Metabolic Syndrome in Mekelle City (n=266)
| Variables | Categories | Metabolic Syndrome | cOR (95% CI) | p-value | aOR (95% CI) | p-value | |
|---|---|---|---|---|---|---|---|
| Yes (n (%)) | No (n (%)) | ||||||
| Age | 20–39 | 19 (11.3) | 149 (88.7) | 1 | 1 | ||
| ≥40 | 39 (39.8) | 59 (60.2) | 5.184 (2.773,9.692) | <0.001* | 2.545 (1.201,5.392) | 0.015* | |
| Sex | Female | 35 (24.6) | 107 (75.4) | 1.436 (0.794,2.597) | 0.231 | ||
| Male | 23 (18.5) | 101 (81.5) | 1 | ||||
| Educational status | Illiterate | 7 (25.9) | 20 (74.1) | 1 | |||
| 1–12 | 30 (19.7) | 122 (80.3) | 0.703 (0.272,1.815) | 0.466 | |||
| >13 | 21 (24.1) | 66 (75.9) | 0.909 (0.337,2.449) | 0.850 | |||
| Body mass index (kg/m2) | <25.0 | 16 (9.1) | 160 (90.9) | 1 | 1 | ||
| ≥25.0 | 42 (46.7) | 48 (53.3) | 8.750 (4.522,16.929) | <0.001* | 5.411 (2.549,11.487) | <0.001* | |
| Monthly income (ranked) | Low | 9 (8.8) | 93 (91.2) | 1 | 1 | ||
| Medium | 21 (25.3) | 62 (74.7) | 3.500 (1.504,8.143) | 0.004* | 2.807 (1.028,7.669) | 0.044* | |
| High | 28 (34.6) | 53 (65.4) | 5.459 (2.396,12.436) | <0.001* | 4.221 (1.606,11.094) | 0.003* | |
| Total Cholesterol (mg/dl) | <200.0 | 26 (13.9) | 161 (86.1) | 1 | 1 | ||
| ≥200.0 | 32 (40.5) | 47 (59.5) | 4.216 (2.288,7.768) | <0.001* | 2.453 (1.172,5.132) | 0.017* | |
| Type of oil | Liquid | 25 (18.8) | 108 (81.2) | 1 | |||
| Solid | 33 (24.8) | 100 (75.2) | 1.426 (0.793,2.563) | 0.236 | |||
| Sitting time per day | <6 hours | 37 (20.4) | 144 (79.6) | 1 | |||
| ≥6 hours | 21 (24.7) | 64 (75.3) | 1.277 (0.693,2.353) | 0.433 | |||
| Waist to hip ratio (M/W) | <0.88/.0.82 | 2 (2.5) | 78 (97.5) | 1 | 1 | ||
| ≥0.88/0.82 | 56 (30.1) | 130 (69.9) | 16.800 (3.988,70.773) | <0.001* | 4.910 (1.076,22.402) | 0.040* | |
| Walking at least 10 minutes daily | Yes | 43 (19.1) | 182 (80.9) | 1 | 1 | ||
| No | 15 (36.6) | 26 (63.4) | 2.442 (1.192,5.002) | 0.015* | 2.847 (1.112,7.290) | 0.029* | |
| Formal exercise | Yes | 3 (9.1) | 30 (90.9) | 1 | 1 | ||
| No | 55 (23.6) | 178 (76.4) | 3.090 (0.908,10.56) | 0.071 | |||
| Current alcohol consumption | Yes | 47 (22.1) | 166 (77.9) | 1.081 (0.516,2.263) | 0.836 | ||
| No | 11 (20.8) | 42 (79.2) | 1 | ||||
Note: Maximum SE: 0.774, Hosmer Lemeshow: 0.721, *Significant association.
Abbreviations: cOR, crude odds ratio; aOR, adjusted odds ratio; CI, confidence interval.